For radiologists who need an immediate second reader, BreastScreening-AI is a product that uses AI to aid breast cancer diagnosis, mitigating the clinical error and offering improvements in terms of clinical performance.

BreastScreening-AI

Unlike the market alternatives, our product differentiates itself by using a user-centered approach, analyzing characteristics of medical behavior so that the assistant can promote better decision-making and trust from clinicians.

BreastScreening-AI

An example of this is our developed explainability and intelligibility techniques, in which our assistant is summarizing the reasons of the AI suggestions visually.

BreastScreening-AI

In this work, we are developing a system that communicates the suggestive recommendation depending on medical characteristics or accuracy of the AI model.

BreastScreening-AI

ADVANTAGE

VALUE

Eliminating the time factor to have a second opinion, our AI solution for medical imaging is raising an autonomous second reader to reduce the medical error by mitigating the number of biopsies and creating a greater performance for the clinical workflow.

Blue ocean strategy turns strategic management on its head by replacing “competitive advantage” with “value innovation” as the primary goal. Firms must create consumer demand and exploit untapped markets. The Focus is on creating new markets.

Raise

Reduce

Create

Current Market

Clinicians who are already using AI in their clinical workflow.

TIER-1 “Soon-to-be”

“Soon-to-be” clinicians who aim to use AI but still waiting for better solutions.

TIER-2 “Refusing”

“Refusing” clinicians who do not trust in AI recommendations as a second reader solution.

TIER-3 “Unexplored”

“Unexplored” noncustomers who are in markets distant from yours.

STEP 3: REACH BEYOND EXISTING CUSTOMERS

CURRENT MARKET

TIER 1

TIER 2

TIER 3

As-Is Portfolio

To-Be Portfolio

Pioneer Value Innovation

Migrator Value Improvement

Settler Value Imitation